ElleS Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: compounded GLP-1 (including oral capsules) within a broad telehealth menu
ElleS scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
ElleS (ElleS Inc.) is a comprehensive compounded telehealth service. Its weight-loss line includes compounded semaglutide and tirzepatide in both injectable and oral-capsule forms (plus microdose), sold as 3- and 6-month packages bundling the telehealth visit, medication, and shipping. It also covers TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+), with Registered Dietitian support. Pricing is not shown publicly (it appears after the CareValidate intake), the pharmacy partner is unnamed, and no LegitScript certification is displayed.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to ElleS
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
ElleS at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $269/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored ElleS
Each dimension is scored algorithmically from ElleS’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.5/10At $269/mo, ElleS runs about 59% above the $170 median for GLP-1 providers.
Effectiveness25%
8.2/10ElleS offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.1/10ElleS's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.5/10Coaching/nutrition support offered.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this ElleS review
Last checked August 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $269–$359/mo across 4 dose/plan tiers — checked August 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with ElleS
We walked ElleS’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a 2-minute clinical assessment.
- 2Licensed clinicians review and approve if appropriate.
- 3If prescribed, GLP-1 medication is delivered with free shipping.
- 4Ongoing support with progress monitoring and dosing adjustments.
- Shows a single $179 program price up front, including consultation, custom dosing, GLP-1 medication, and free delivery.
- Emphasizes 'No subscription' and transparent pricing.
- A telehealth video visit occurs only 'if needed'; many patients approved without a call.
- Free delivery of prescribed medication.
GLP-1 medications ElleS offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check ElleS's current pricing and active discounts before you decide.
What we like
- Compounded semaglutide and tirzepatide in both injectable and oral-capsule forms, plus microdose options
- Packages bundle the telehealth visit, medication, and shipping; Registered Dietitian support included
- Full legal suite published — Terms, Privacy Policy, Privacy Practices, and Medical Consent
- Broad menu: also TRT, HRT (estradiol), sexual health, hair loss, and longevity (sermorelin, NAD+)
Watch-outs
- Pricing not shown publicly — products and costs appear only after the intake flow
- Sold as 3- and 6-month packages rather than simple monthly plans
- Compounding pharmacy partner not named ('made in licensed US facilities')
- Not LegitScript-certified (no certification displayed)
Is ElleS worth it?
ElleS built its program around one core idea: compounded GLP-1 (including oral capsules) within a broad telehealth menu. It runs $269/month — a premium versus the rest of the category, so its specific extras need to earn that difference. Its standout is a needle-free oral option, which very few providers offer.
Beyond the medication itself, ElleS offers a microdosing option. It also includes coaching or dietitian support and offers NAD+ or peptide add-ons.
How much ElleS actually costs
Semaglutide runs $269/month, tirzepatide runs $359/month, semaglutide runs $299/month, and tirzepatide runs $349/month.
For context, the typical ongoing price across the GLP-1 providers we track is around $170/month. ElleS's standing rate sits at the premium end of that range, well above the cheapest options in the category.
For a direct comparison, Maximus runs semaglutide and tirzepatide from $249.99/month — worth pricing against ElleS before you commit.
Medications: what ElleS prescribes
ElleS prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the pair backed by the largest published weight-loss trials.
ElleS's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who ElleS is best for — and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. We explain in detail how we weigh medical oversight, safety, and pricing transparency in our scoring methodology, which is worth reading before you sign up with any provider.
Bottom line
ElleS costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere.
The Bottom Line
ElleS scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with ElleS?
Starting at $269/month. See current pricing and start your free consultation.
ElleS might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Fella Health.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this ElleS review:
Sources & methodology — as of September 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See ElleS's current pricing
Plans start at $269/month. Start your free consultation to check eligibility and today's price.